Zacks Investment Research · SOLV · October 23, 2026SOLV Wins FDA Clearance to Combine Restrata Matrix With V.A.C.TherapyGet the app for moreExplore stock news, insights and company research.Get the app →Source: Zacks Investment Research ↗